FDA product code SCE: Ivd Offered As Ldt, First Marketed Before May 6, 2024, Not Modified Beyond Scope Described In Preamble To Ldt Final Rule

SCE is the FDA product code for ivd offered as ldt, first marketed before may 6, 2024, not modified beyond scope described in preamble to ldt final rule. It is a Not classified device, reviewed by the Clinical Chemistry panel. Devices under SCE reach the market by 510(k) exempt; FDA lists no cleared 510(k)s for it.

Definition

Currently marketed in vitro diagnostic products (IVDs) offered as laboratory developed tests (LDTs) that were first marketed prior to May 6, 2024, and not modified following that date or not modified beyond the scope described in section V.B.3 of the preamble to the LDT Final Rule (89 FR 37286).

Classification

FieldValue
Device nameIvd Offered As Ldt, First Marketed Before May 6, 2024, Not Modified Beyond Scope Described In Preamble To Ldt Final Rule
Device classNot classified
Review panelCH — Clinical Chemistry
Medical specialtyUnknown
Premarket route510(k) exempt

Recalls for SCE devices

FDA recall records list no recalls for product code SCE.

Frequently asked questions

What is FDA product code SCE?

SCE is the FDA product code for ivd offered as ldt, first marketed before may 6, 2024, not modified beyond scope described in preamble to ldt final rule. It is a Not classified device, reviewed by the Clinical Chemistry panel.

What device class is SCE?

Not classified. Typical premarket route: 510(k) exempt.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times